Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Kamlesh Khunti a Clinical Governance Research and
Development Unit, Department of General Practice and Primary Health
Care, University of Leicester, Leicester LE5 4PW, b Leicestershire Primary
Care Audit Group, Leicester General Hospital, Leicester LE5 4PW, c Leicestershire Health Authority, Leicester
LE5 4QF
Correspondence to: Dr Khunti kk22{at}le.ac.uk
The Antiplatelet Trialists' Collaboration provided
convincing evidence of benefits of aspirin prophylaxis in patients
after myocardial infarction,1 but many such patients do
not receive it.
2 3
Since most patients are followed up in
primary care, practices need to implement methods of improving aspirin
prophylaxis in these patients. The aim of this multipractice audit led
by a primary care audit group was to assess and improve levels of prescribing of prophylactic aspirin for patients after myocardial infarction in Leicestershire.
All Leicestershire practices (n = 154) were invited
to take part and were offered six hours' postgraduate allowance for
completing the full audit cycle. The health authority supplied data to
the participating practices on currently registered patients who had been discharged after myocardial infarction over the past five years.
These data were retrieved from the hospital information system and were
checked against the list of registered patients. Patients who had died
and those who had moved away were removed from the list. Practices were
guaranteed anonymity on their audit results.
A retrospective record review was carried out in general practice by
the practice staff, who were asked to check the status of each patient
relating to his or her eligibility for aspirin prophylaxis and any
contraindications to aspirin. All results were entered on to piloted
data collection forms that were returned to the audit group for
analysis. Practices received aggregated feedback of results of the
first phase and were encouraged to develop multiple strategies for
improvement in response to their results. Strategies for improvement
included tagging the notes and inviting patients to attend for review.
A reaudit was carried out after six months.
Forty five practices with 149 partners (mean 3.3; range 1-8) took part
in the audit. Ten practices were single handed, 31 had two to five
partners, and four had six or more partners. The practices covered
270 036 patients, of whom 1264 (72.8% male) were eligible to be
included in the audit. The table shows the results of the first audit
(phase 1) and the reaudit after feedback and implementation of change
(phase 2).
Our study shows that just over 15% of patients received
suboptimal treatment in the first audit, a standard similar to those observed in recent surveys.
2 3
Previous audits, however, did not implement change and complete the audit cycle. In contrast, our
study shows that multipractice audit and feedback of comparisons between peers leads to improvements in the care of patients after myocardial infarction. Our study has several limitations: the health
authority could provide an accurate list of patients after myocardial
infarction only in the past five years; all practices were self
selected; and the record review was carried out by the practices. The
results therefore probably overestimate the quality of care of patients
after myocardial infarction.3
Participation in audit is influenced by many factors, with lack of time
and skill being two of the common barriers.4 A time
consuming and difficult part of undertaking audit is compiling a
register of patients with the condition being audited. In our study the
health authority made this register readily available to the
practices.
![]()
Subjects, methods, and results
Top
Subjects, methods, and results
Comment
References
![]()
Comment
Top
Subjects, methods, and results
Comment
References
The white paper The New NHS places great emphasis on
improving quality of care with the introduction of clinical governance and clinical effectiveness.5 Health authorities will have
a key role in implementing clinical governance and ensuring that clinicians are encouraged to move towards evidence based practice. Our
study shows that collaborative audit with anonymised feedback can
reduce the gap between current practice and practice that is evidence based.
| |
Acknowledgments |
|---|
We thank all the practices that participated in the audit.
Contributors: SR, JS, and FA were responsible for the audit design. JS supplied the list of patients after myocardial infarction to the practices. KK gave feedback to the practices after the first phase of the audit and suggested methods of implementing change. KK and SR were responsible for the data analysis. KK was responsible for the initial drafting of the paper, and all authors made contributions to subsequent drafts. KK is the guarantor.
| |
Footnotes |
|---|
Funding: Leicestershire Primary Care Audit Group is an independent audit group and is funded by Leicestershire Health Authority. The Clinical Governance Research and Development Unit is core funded by Leicestershire Health Authority and Trent region.
Competing interests: None declared.
| |
References |
|---|
|
|
|---|
| 1. |
Antiplatelets Trialists' Collaboration.
Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients.
BMJ
1994;
308:
81-106 |
| 2. |
Whitford DL, Southern AJ.
Audit of secondary prophylaxis after myocardial infarction.
BMJ
1994;
309:
1268-1269 |
| 3. |
Bradley F, Morgan S, Smith H, Mant D, for the Wessex Research Network (WReN).
Preventative care for patients following myocardial infarction.
Fam Pract
1997;
14:
220-226 |
| 4. |
Chambers R, Bowyer S, Campbell I.
Investigation into the attitudes of general practitioners in Staffordshire to medical audit.
Quality in Health Care
1996;
5:
13-19 |
| 5. | Secretary of State for Health. The new NHS. London: Stationery Office , 1997(Cm3807.) |
(Accepted 8 March 1999)